Statistics

Total Visits

Views
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial43

Select a period of time:

Number of views in the range

Views
Trastuzumab or lapatinib with standard chemotherapy for HER2-positive breast cancer: results from the GEICAM/2006-14 trial29

Views

Views
March 202516
April 20252
May 20250
June 20250
July 202511
August 20250
September 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore16
Brazil9
Canada1
Spain1
Turkey1
United States1
 

Top cities views

Views
Antakya1
Araruna1
Blumenau1
Butiá1
Campinas1
Campo Bom1
Codó1
Council Bluffs1
Ribeirão Gabiroba1
São Paulo1